-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
eFFECTOR Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2023.
- eFFECTOR Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending March 31, 2024 was -2.16 USD/shares, a 63.8% increase year-over-year.
- eFFECTOR Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending March 31, 2024 was -12.6 USD/shares, a 36.5% increase year-over-year.
- eFFECTOR Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -16.4 USD/shares, a 19% decline from 2022.
- eFFECTOR Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -13.8 USD/shares, a 1410% decline from 2021.
- eFFECTOR Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was 1.05 USD/shares, a 775% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)